EMIS Acquires Majority Stake in Pharmacy Software Company Rx Systems Limited

EMIS Group plcEMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software to GPs, today announces that it has acquired 78.9% of the issued share capital of Rx Systems Limited ("RX"), a pharmacy software and services company, for a total consideration of up to £9.95 million.

Rx Systems has a 20.5% share of the community pharmacy market; EMIS believes that further growth in the market share can be achieved post-acquisition.

The acquisition is an important element of EMIS' continuing drive to provide 'joined-up' healthcare for NHS patients. It is anticipated that future integration of EMIS and Rx Systems technologies will enable further streamlining of electronic prescription services, benefiting patients, GPs and the 2,500 community pharmacies using Rx Systems' ProScript dispensary management system.

Future developments will see pharmacists benefit from the link with GP practices using EMIS Access, the award winning secure online patient portal. This already allows patients to request repeat medication via internet, mobile phone or digital TV, saving time and streamlining the prescription process considerably.

There will be further advantages from interoperability between EMIS Web, EMIS' next generation system, and ProScript. EMIS Web is currently being tested for EPS2 paired with ProScript.

Sean Riddell, EMIS CEO, said: "Rx Systems software has a strong reputation and a loyal community pharmacy customer base. Joining forces enables both EMIS and Rx Systems to identify the best way to provide GPs and pharmacists with appropriate levels of interoperability to further improve patient care and efficiencies in the prescribing environment. This means real benefits for patients, GPs and pharmacists alike."

For further information, please visit:
http://www.emis-online.com

Related news articles:

EPS2 (Release 2 of Connecting for Health's Electronic Prescription System) will provide increased functionality for pharmacists, GPs and patients including nomination of pharmacies, electronic prescription signing and electronic repeat dispensing.

About EMIS Group plc
EMIS was established in March 1987 by two GPs who identified an opportunity to develop and supply practice management software and computerise patients’ electronic health records, then kept on paper at GPs' surgeries.

The Group has since become the UK's leading supplier of software and related services to GP surgeries and now leads the market, with around 39 million patient records held on its platform.

The Group's latest product, EMIS Web, electronically connects GPs with other NHS professionals by enabling secure, shared, centrally hosted access to patients' cradle-to-grave electronic health records held at the Group’s data centres. The transformational system has the capability to interconnect with other NHS patient data systems to:

  • save time and money by eliminating paperwork and the re-inputting of data;
  • significantly reduce patient waiting times; and
  • reduce the risk of prescribing and treatment errors.

EMIS is headquartered in Leeds.

About Rx Systems
Rx Systems has grown rapidly since it began trading in 2004. Based in Hertfordshire and operating throughout the UK, Rx Systems has developed a range of integrated pharmacy and retail systems and services for the community pharmacy, including its core product, ProScript, a windows based dispensary management system. www.rxsystems.co.uk.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...